The effects of thiamine deprivation, and oxythiamine- and pyrithiamine-treatment on cardiac function and metabolism in the rat.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D001835:Body Weight; D002245:Carbon Dioxide / Q000378:metabolism; D006332:Cardiomegaly / Q000209:etiology; D004562:Electrocardiography; D006321:Heart / Q000033:anatomy & histology / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007773:Lactates / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009929:Organ Size; D010725:Phosphocreatine / Q000378:metabolism; D011726:Pyridinium Compounds / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D013831:Thiamine / Q000037:antagonists & inhibitors*; D013832:Thiamine Deficiency / Q000378:metabolism / Q000503:physiopathology; D013844:Thiazoles / Q000494:pharmacology*
D000963:Antimetabolites; D007773:Lactates; D011726:Pyridinium Compounds; D011743:Pyrimidines; D011773:Pyruvates; D013844:Thiazoles; D010725:Phosphocreatine; D002245:Carbon Dioxide; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D013831:Thiamine